HighTower Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-200
Closed -$1K 2435
2019
Q1
$1K Buy
+200
New +$9.05K ﹤0.01% 2273

Other funds holding GMED

HighTower Advisors's GMED Position: Q1 2026 in Review

HighTower Advisors reduced its Globus Medical (GMED) stake by 42% in Q1 2026, selling an estimated $1.54M and leaving 23,626 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

HighTower Advisors first reported a position in GMED in Q2 2015 and has held it in 36 quarters since. The position peaked at $3.56M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • HighTower Advisors held 23,626 shares of Globus Medical worth $2.04M as of Q1 2026.
  • HighTower Advisors sold 17,162 Globus Medical shares in Q1 2026, an estimated $1.54M.
  • Globus Medical made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1705 holding.
  • HighTower Advisors first reported a position in Globus Medical in Q2 2015 and has held it in 36 quarters since.
  • HighTower Advisors's Globus Medical position peaked at $3.56M in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.